AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application
HONG KONG,Feb. 12,2025--AIM Vaccine Co.,Ltd. (06660.HK),a leading PRC vaccine company,published an announcement on February 11,2025,announced that its independently developed mRNA shingles vaccine has